These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3620411)

  • 41. Grand multiparity and reproductive cancer in the Jerusalem Perinatal Study Cohort.
    Paltiel O; Tajuddin SM; Polanker Y; Yazdgerdi S; Manor O; Friedlander Y; Harlap S; Calderon-Margalit R
    Cancer Causes Control; 2016 Feb; 27(2):237-47. PubMed ID: 26669321
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer and the use of estrogens.
    Gambrell RD
    Int J Fertil; 1986; 31(2):112-3, 116-22. PubMed ID: 2875032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study.
    Kotsopoulos J; Huzarski T; Gronwald J; Moller P; Lynch HT; Neuhausen SL; Senter L; Demsky R; Foulkes WD; Eng C; Karlan B; Tung N; Singer CF; Sun P; Lubinski J; Narod SA
    Breast Cancer Res Treat; 2016 Jan; 155(2):365-73. PubMed ID: 26780555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Breast cancer risk in the WHI study: the problem of obesity.
    Kuhl H
    Maturitas; 2005 May; 51(1):83-97. PubMed ID: 15883113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens.
    Gambrell RD; Massey FM; Castaneda TA; Ugenas AJ; Ricci CA
    J Am Geriatr Soc; 1979 Sep; 27(9):389-94. PubMed ID: 469150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex steroids and cancer.
    Gambrell RD
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):191-206. PubMed ID: 3306519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Use of progestogen therapy.
    Gambrell RD
    Am J Obstet Gynecol; 1987 May; 156(5):1304-13. PubMed ID: 3578452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Risk of Breast Cancer in Women Using Menopausal Hormone Replacement Therapy in Taiwan.
    Liu JY; Chen TJ; Hwang SJ
    Int J Environ Res Public Health; 2016 May; 13(5):. PubMed ID: 27187426
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exogenous and endogenous hormones and breast cancer.
    Chen WY
    Best Pract Res Clin Endocrinol Metab; 2008 Aug; 22(4):573-85. PubMed ID: 18971119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reducing cancer risk in women through lifestyle-mediated changes in hormone levels.
    Pike MC
    Cancer Detect Prev; 1990; 14(6):595-607. PubMed ID: 2257556
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the age-dependent association between cancer of the breast and of the endometrium. A nationwide cohort study.
    Adami HO; Krusemo UB; Bergkvist L; Persson I; Pettersson B
    Br J Cancer; 1987 Jan; 55(1):77-80. PubMed ID: 3814480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are mammotropic hormones mainly permissive for the development of breast cancer?
    Trichopoulos D; Bamia C; Lagiou P; Trichopoulou A
    Int J Cancer; 2006 Jun; 118(11):2863-5. PubMed ID: 16381008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
    Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
    Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk.
    Spicer DV; Ursin G; Parisky YR; Pearce JG; Shoupe D; Pike A; Pike MC
    J Natl Cancer Inst; 1994 Mar; 86(6):431-6. PubMed ID: 8120917
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.
    Lethaby A; Farquhar C; Sarkis A; Roberts H; Jepson R; Barlow D
    Cochrane Database Syst Rev; 2000; (2):CD000402. PubMed ID: 10796715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hormones and breast cancer.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2004; 10(4):281-93. PubMed ID: 15192054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The possible role of female sex hormones in milk from pregnant cows in the development of breast, ovarian and corpus uteri cancers.
    Ganmaa D; Sato A
    Med Hypotheses; 2005; 65(6):1028-37. PubMed ID: 16125328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.